Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Markovic

Showing results (151-160 of 368) with videos related to

Pageof 37
Sort By:
The New England Journal of Medicine|February 4, 1999
Cocaine and tobacco use and the risk of spontaneous abortionR B Ness, J A Grisso, N Hirschinger, et al.
Cancer Research|May 20, 2016
Antibody-Targeted Chemotherapy for the Treatment of MelanomaWendy K Nevala, Sarah A Buhrow, Daniel J Knauer, et al.
Melanoma Research|November 15, 2014
The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanomaJustin C Moser, Jose S Pulido, Roxana S Dronca, et al.
British Journal of Haematology|May 25, 2002
Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's diseaseLuis F Porrata, David J Inwards, Ivana N Micallef, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2020
Brief Communication: Immune Checkpoint Inhibitor-induced Diaphragmatic Dysfunction: A Case SeriesWilliam J Archibald, Dagny K Anderson, Thomas J Breen, et al.
Cancer Research|September 5, 2019
Correction: Antibody-Targeted Chemotherapy for the Treatment of MelanomaWendy K Nevala, Sarah A Buhrow, Daniel J Knauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2009
Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanomaWendy K Nevala, Celine M Vachon, Alexey A Leontovich, et al.
American Journal of Hematology|June 6, 2008
mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)Shernan G Holtan, Luis F Porrata, Joseph P Colgan, et al.
Journal of Neurosurgery|January 24, 2015
Perineural spread of malignant melanoma from the mandible to the brachial plexus: case reportCarlos E Restrepo, Robert J Spinner, B Matthew Howe, et al.
Journal of Translational Medicine|December 2, 2009
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?Brendon J Coventry, Martin L Ashdown, Michael A Quinn, et al.
Pageof 37

Showing results (151-160 of 368) with videos related to

Sort By:
Pageof 37
The New England Journal of Medicine|February 4, 1999
Cocaine and tobacco use and the risk of spontaneous abortionR B Ness, J A Grisso, N Hirschinger, et al.
Cancer Research|May 20, 2016
Antibody-Targeted Chemotherapy for the Treatment of MelanomaWendy K Nevala, Sarah A Buhrow, Daniel J Knauer, et al.
Melanoma Research|November 15, 2014
The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanomaJustin C Moser, Jose S Pulido, Roxana S Dronca, et al.
British Journal of Haematology|May 25, 2002
Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's diseaseLuis F Porrata, David J Inwards, Ivana N Micallef, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2020
Brief Communication: Immune Checkpoint Inhibitor-induced Diaphragmatic Dysfunction: A Case SeriesWilliam J Archibald, Dagny K Anderson, Thomas J Breen, et al.
Cancer Research|September 5, 2019
Correction: Antibody-Targeted Chemotherapy for the Treatment of MelanomaWendy K Nevala, Sarah A Buhrow, Daniel J Knauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2009
Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanomaWendy K Nevala, Celine M Vachon, Alexey A Leontovich, et al.
American Journal of Hematology|June 6, 2008
mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)Shernan G Holtan, Luis F Porrata, Joseph P Colgan, et al.
Journal of Neurosurgery|January 24, 2015
Perineural spread of malignant melanoma from the mandible to the brachial plexus: case reportCarlos E Restrepo, Robert J Spinner, B Matthew Howe, et al.
Journal of Translational Medicine|December 2, 2009
CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?Brendon J Coventry, Martin L Ashdown, Michael A Quinn, et al.
Pageof 37